VIVE (Viveve Medical) Total Equity: $1.18 Mil (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VIVE Viveve Medical Inc VIVE
12 GF Score
Price $0.00
View Full Analysis

What is Viveve Medical Total Equity?

Viveve Medical VIVE 12 Total Equity is $1.18 Mil as of Sep. 2022. GuruFocus rates VIVE with a GF Score™ of 12/100.

Viveve Medical's total equity for the quarter that ended in Sep. 2022 was $1.18 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Viveve Medical Total Equity Historical Data

* Premium members only.

The historical data trend for Viveve Medical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viveve Medical Total Equity Chart

Viveve Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.60 4.91 16.52 6.97 15.07

Viveve Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.37 15.07 10.16 5.28 1.18
VIVE
12GF Score
Viveve Medical Inc VIVE
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viveve Medical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Viveve Medical's Total Equity for the fiscal year that ended in Dec. 2021 is calculated as

Total Equity=Total Assets(Q: Dec. 2021 )-Total Liabilities(Q: Dec. 2021 )
=25.913-10.847
=15.07

Viveve Medical's Total Equity for the quarter that ended in Sep. 2022 is calculated as

Total Equity=Total Assets(Q: Sep. 2022 )-Total Liabilities(Q: Sep. 2022 )
=12.154-10.97
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $1.18 Mil mean?
Viveve Medical (VIVE) has a Total Equity of $1.18 Mil as of Sep. 2022. The total amount of equity as record on a company's balance sheet. View historical data for Viveve Medical and its competitors.
Is Viveve Medical's Total Equity too high?
Viveve Medical's current Total Equity is $1.18 Mil. Overall, Viveve Medical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Viveve Medical's Total Equity compare to NNMX and LHDXQ?
Viveve Medical's Total Equity of $1.18 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Viveve Medical and its competitors. Viveve Medical's current Total Equity is $1.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viveve Medical stock overvalued right now?
Viveve Medical (VIVE) has a current Total Equity of $1.18 Mil. The current Total Equity is $1.18 Mil. Viveve Medical's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Viveve Medical (VIVE), the current Total Equity is $1.18 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viveve Medical Business Description

Address 345 Inverness Drive South, Building B, Suite 250, Englewood, CO, USA, 80112
Viveve Medical Inc designs, develops, manufactures and markets a platform medical technology. Its Cryogen-cooled Monopolar Radiofrequency technology is delivered through a radiofrequency generator, handpiece and treatment tip, called the Viveve System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The Viveve System is indicated for use and being marketed for use in general surgical procedures for electrocoagulation and hemostasis in the United States. It has a business presence in the US, Asia Pacific, Canada, Europe and Middle East and Latin America.
12GF Score

Get the complete analysis for VIVE

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price